Skip to main content

Cancer Immunotherapy group

Projects Karine Breckpot

IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”

12/01/2021
IOFPOC42: IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”

Devoogdt, N. , Breckpot, K. , Meeus, F. , De Groof, T. & De Vlaeminck, Y.

1/01/21 → 31/12/22

Project : Applied

High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity

22/12/2020
FWOAL1019: High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity

Breckpot, K.

1/01/21 → 31/12/24

Project : Fundamental

CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.

19/10/2020
FWOSB101: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.

Meeus, F. & Breckpot, K.

1/11/20 → 31/10/22

Project : Fundamental

CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors

18/09/2020
ani257: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors

Breckpot, K.

1/11/20 → 31/10/21

Project : Fundamental

Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

14/07/2020
BRGRD44: Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

Keyaerts, M. , Krasniqi, A. , Breckpot, K. & Goyvaerts, C.

1/07/20 → 30/06/23

Project : Applied

Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0

16/06/2020
OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0

Rooman, I. , Bouwens, L. , Heimberg, H. , Neyns, B. , Vranken, W. , Vanhaecke, T. , Massie, A. , van Grunsven, L. , De Bruyne, E. , De Bundel, D. , Forsyth, R. , Breckpot, K. , Van Dooren, S. , De...

ICON project PERSOMED

04/02/2020
VLAHLT1: ICON project PERSOMED

Breckpot, K. & Thielemans, K.

1/10/19 → 30/09/22

Project : Applied

GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

17/12/2019
IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Lahoutte, T. , Devoogdt, N. , Keyaerts, M. , Van Ginderachter, J. , Laoui, D. , Raes, G. , Breckpot, K. & Goyvaerts, C.

1/01/20 → 31/12/24...

Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints

11/10/2019
FWOSB81: Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints

Breckpot, K. , Devoogdt, N. , Keyaerts, M. & Awad, R. M.

1/11/19 → 31/10/21

Project : Fundamental

Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.

11/10/2019
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.

Breckpot, K. , Devoogdt, N. , D'Huyvetter, M. , Keyaerts, M. & Ertveldt, T.

1/11/19 → 31/10/21

Project : Fundamental

Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)

16/04/2019
FWOAL934: Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)

Breckpot, K. , Keyaerts, M. , Barbé, K. & De Smedt, S.

1/01/19 → 31/12/22

Project : Fundamental

Prioritization of neoantigens by the combination of in silico search and mass spectrometry.

31/01/2019
ANI216: Prioritization of neoantigens by the combination of in silico search and mass spectrometry.

Thielemans, K. & Breckpot, K.

1/01/19 → 31/12/22

Project : Fundamental

Projects Cleo Goyvaerts

EUTOPIA Young Leaders Academy fellowship

08/10/2021
OZR3808: EUTOPIA Young Leaders Academy fellowship

Goyvaerts, C.

1/10/21 → 30/09/23

Project : Fundamental

Bone marrow niche – lung cancer crosstalk: gossip or fatal choice of words?

20/07/2021
OZRIFTM9: Bone marrow niche – lung cancer crosstalk: gossip or fatal choice of words?

Goyvaerts, C. & Calderon Espinosa, E. S.

1/10/21 → 30/09/25

Project : Fundamental

Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.

22/12/2020
FWOAL1006: Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.

Goyvaerts, C.

1/01/21 → 31/12/24

Project : Fundamental

Creation of a 3D CRiMe scene to unravel Cytotoxic T cell Resistant Mechanisms

16/10/2020
AIIFUND64: Creation of a 3D CRiMe scene to unravel Cytotoxic T cell Resistant Mechanisms

Goyvaerts, C.

1/04/20 → 28/02/22

Project : Fundamental

Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

14/07/2020
BRGRD44: Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

Keyaerts, M. , Krasniqi, A. , Breckpot, K. & Goyvaerts, C.

1/07/20 → 30/06/23

Project : Applied

GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

17/12/2019
IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Lahoutte, T. , Devoogdt, N. , Keyaerts, M. , Van Ginderachter, J. , Laoui, D. , Raes, G. , Breckpot, K. & Goyvaerts, C.

1/01/20 → 31/12/24...